EpiBiologics
Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...
$107MSeries B
Role not disclosedNV
Novartis Venture Fund (NVF)
Activity from announced rounds
Activity in this selectionbelvedere-trading-f14c94b7
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $107M 1 disclosed · full round size, not this investor’s share